Close

Acadia Pharmaceuticals (ACAD) PT Raised to $54 at Jefferies

November 5, 2020 8:09 AM EST
Get Alerts ACAD Hot Sheet
Price: $18.30 +0.55%

Rating Summary:
    14 Buy, 11 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $54.00 (from $53.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change